Literature DB >> 9804707

Diagnosing multidrug resistant tuberculosis in Britain. Clinical suspicion should drive rapid diagnosis.

F A Drobniewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9804707      PMCID： PMC1114199          DOI： 10.1136/bmj.317.7168.1263

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Is death inevitable with multiresistant TB plus HIV infection?

Authors:  F Drobniewski
Journal:  Lancet       Date:  1997-01-11       Impact factor: 79.321

2.  Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring Project.

Authors:  M C Raviglione; C Dye; S Schmidt; A Kochi
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

3.  Rapid diagnostic tests for tuberculosis: progress but no gold standard.

Authors:  P F Barnes
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

4.  Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories.

Authors:  G T Noordhoek; A H Kolk; G Bjune; D Catty; J W Dale; P E Fine; P Godfrey-Faussett; S N Cho; T Shinnick; S B Svenson
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

Review 5.  The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis--a molecular story.

Authors:  F A Drobniewski; S M Wilson
Journal:  J Med Microbiol       Date:  1998-03       Impact factor: 2.472

6.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

7.  Improved outcomes for patients with multidrug-resistant tuberculosis.

Authors:  G S Turett; E E Telzak; L V Torian; S Blum; D Alland; I Weisfuse; B A Fazal
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

8.  An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital.

Authors:  A S Breathnach; A de Ruiter; G M Holdsworth; N T Bateman; D G O'Sullivan; P J Rees; D Snashall; H J Milburn; B S Peters; J Watson; F A Drobniewski; G L French
Journal:  J Hosp Infect       Date:  1998-06       Impact factor: 3.926
  8 in total
  7 in total

1.  More financial resources must be provided for multidrug resistant TB.

Authors:  M L Schmid; M W McKendrick; S T Green; E J Ridgway
Journal:  BMJ       Date:  1999-04-17

Review 2.  Modern laboratory diagnosis of mycobacterial infections.

Authors:  S A Watterson; F A Drobniewski
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

3.  Drug-resistant tuberculosis.

Authors:  P D Davies
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

4.  Outbreak of isoniazid resistant tuberculosis in north London.

Authors:  M C Ruddy; A P Davies; M D Yates; S Yates; S Balasegaram; Y Drabu; B Patel; S Lozewicz; S Sen; M Bahl; E James; M Lipman; G Duckworth; J M Watson; M Piper; F A Drobniewski; H Maguire
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

5.  Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999.

Authors:  T Djuretic; J Herbert; F Drobniewski; M Yates; E G Smith; J G Magee; R Williams; P Flanagan; B Watt; A Rayner; M Crowe; M V Chadwick; A M Middleton; J M Watson
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

6.  A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK.

Authors:  F Drobniewski; I Eltringham; C Graham; J G Magee; E G Smith; B Watt
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 7.  Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation.

Authors:  Francis Drobniewski; Vladyslav Nikolayevskyy; Horst Maxeiner; Yanina Balabanova; Nicola Casali; Irina Kontsevaya; Olga Ignatyeva
Journal:  BMC Med       Date:  2013-08-29       Impact factor: 8.775
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.